Minerva Neurosciences's total assets for Q2 2025 were $30.42M, a decrease of -18.10% from the previous quarter. NERV total liabilities were $62.53M for the fiscal quarter, a -0.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.